Four Tree Island Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Four Tree Island Advisory's BMY Position: Q1 2026 in Review
Four Tree Island Advisory held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 58,337 shares worth $3.54M. The position accounts for 1.79% of the portfolio, ranked #10.
Four Tree Island Advisory first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.06M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Four Tree Island Advisory held 58,337 shares of Bristol-Myers Squibb worth $3.54M as of Q1 2026.
- Four Tree Island Advisory left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 1.79% of Four Tree Island Advisory's portfolio in Q1 2026, its #10 holding.
- Four Tree Island Advisory first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Four Tree Island Advisory's Bristol-Myers Squibb position peaked at $4.06M in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Four Tree Island Advisory's 13F filing for Q1 2026, filed 11 May 2026.